SS Innovations International Inc. (NASDAQ: SSII) announced it will showcase its SSi Mantra surgical robotic system at the Society of Robotic Surgery (SRS) 2026 Annual Meeting, scheduled for July 23-26 in Hollywood, Florida (https://ibn.fm/FkgsY). The presentation will include a live kidney telesurgery broadcast from India, demonstrating the remote capabilities of the SSi Mantra platform.
Chairman and CEO Dr. Sudhir Srivastava is slated to participate in multiple conference sessions covering telesurgery, robotic surgery adoption, and regulatory developments. The company highlighted that as of July 6, 2026, more than 12,375 procedures have been completed using the SSi Mantra system, including cardiac, pediatric, and telesurgical procedures. Additionally, approximately 2,100 physicians have been trained on the platform, which has been used across more than 170 different surgical procedures.
The SRS Annual Meeting is one of the largest gatherings of robotic surgery specialists, and SS Innovations’ presence underscores its expanding clinical footprint and growing focus on remote surgical capabilities. The live telesurgery—a partial nephrectomy performed remotely—will be a focal point of the event, highlighting the potential for surgical robots to bridge geographic gaps in specialized care.
This news matters because SS Innovations is positioning itself as a competitor in the global surgical robotics market, which is dominated by established players like Intuitive Surgical. The SSi Mantra’s telesurgery capabilities could expand access to advanced surgical care in underserved regions, reducing the need for patients to travel to major medical centers. For hospitals and healthcare systems, the platform may offer a cost-effective alternative to existing robotic systems, while its growing procedure count and physician training base suggest increasing clinical adoption.
For industry leaders, the demonstration at SRS 2026 signals that telesurgery is moving from experimental to practical application. Regulatory developments in this area may accelerate as more data on safety and efficacy become available. Investors should note that SS Innovations’ progress in expanding its global clinical footprint could impact the competitive landscape, potentially driving innovation and pricing changes in surgical robotics.
The company’s latest news and updates are available in its newsroom at https://ibn.fm/SSII. As the SSi Mantra continues to gain traction, the implications for healthcare delivery, particularly in remote and rural settings, are significant. The ability to perform complex surgeries remotely could reshape how surgical care is provided, making it more accessible and efficient.
